Endothelin receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 285/14 (2006.01) A61K 31/41 (2006.01) C07D 271/12 (2006.01) C07D 413/04 (2006.01) C07D 417/04 (2006.01)

Patent

CA 2297315

The invention relates to novel compounds of formula (I), wherein R represents group (1), X stands for O or S, and R1, R2, R3, R4, R5 and R6 have the meaning cited in Claim 1, or a tauomeric cyclized form. The invention further relates to (E) isomers and their salts. Said novel derivatives exhibit endothelin- receptor antagonistic properties.

Des nouveaux composés correspondant à la formule (I), dans laquelle R représente le groupe (1), X représente O ou S et R?1¿, R?2¿, R?3¿, R?4¿, R?5¿ et R?6¿ correspondent à la définition donnée dans la revendication 1, ou bien une forme tautomère fermée en cycle, ainsi que les isomère (E) et les sels de ces nouveaux composés ont des propriétés antagonistes vis-à-vis des récepteurs de l'endothéline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Endothelin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1355914

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.